Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Survey highlights need for primary care guidance on NSAID use

10.06.2005


New guidance on NSAID (non-steroidal anti-inflammatory drug) use is urgently needed to ensure the best patient care, European experts said today. The news coincides with the results from a European survey of 626 arthritis patients which found that many are confused and worried about the potential side-effects of their medication.



Primary care physicians now face an increasingly limited range of prescribing options for long-term arthritis pain management, following the withdrawal of Vioxx (rofecoxib) and the suspension of Bextra (valdecoxib), and the safety restrictions on the use of remaining drugs in the COX-2 selective NSAID class.

All NSAIDs – which include aspirin and ibuprofen – carry a risk of distressing and sometimes fatal upper gastrointestinal (GI) side-effects. For example, each year in the UK NSAIDs cause approximately 3,500 hospitalisations for, and 400 deaths from, ulcer bleeding in patients aged 60 years and above.


Despite these well-known risks, more than 45 per cent (46.18 per cent) of those patients participating in the survey felt they had received little or no support on managing the side-effects of their treatment from their doctor. More than one in six patients with arthritis (17.8 per cent) were still unaware of potential drug side-effects.

Professor Greg Rubin, Chairman of the European Society for Primary Care Gastroenterology (ESPCG) and Professor of Primary Care at the University of Sunderland, UK, said: “These results confirm our current thinking, that there is a lot of conflicting information on the risks of NSAIDs, including COX-2 selective NSAIDs. This makes it more difficult for primary care physicians to weigh up the risks and benefits of each treatment option and thus to make the correct decision for each individual patient. The ESPCG is eager to develop guidance to support European primary care practitioners in this decision making process.”

A cost-effectiveness study recently found that the combination of a non-selective NSAID and a proton pump inhibitor (PPI) is a more cost-effective treatment option than a COX-2 selective NSAID alone in preventing ulcer complications for many arthritis patients, particularly those at high risk of a GI or cardiovascular adverse event.

Combining NSAID therapy with Nexium effectively resolves symptoms of heartburn and acid regurgitation, as well as preventing peptic and gastric ulcers in at-risk patients, and healing gastric ulcers associated with long-term use of NSAIDs, including COX-2 selective NSAIDs.

Results of the European survey also showed that 25 per cent of people with arthritis had been offered treatment to protect against the upper GI side-effects of their medication.

Lucy Hughes | alfa
Further information:
http://www.hillandknowlton.com

More articles from Health and Medicine:

nachricht A better way to measure the stiffness of cancer cells
01.03.2017 | Duke University

nachricht Humans have three times more brown body fat
01.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

A better way to measure the stiffness of cancer cells

01.03.2017 | Health and Medicine

Exploring the mysteries of supercooled water

01.03.2017 | Physics and Astronomy

Research team of the HAW Hamburg reanimated ancestral microbe from the depth of the earth

01.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>